Immunological impact of intraperitoneal and intravenous chemotherapy in ovarian cancer, translational analyses of the Phase 3 iPocc trial.
Ogasawara A, Matsushita H, Tan TZ, Shintani D, Ye J, Nagao S, Demachi-Okamura A, Muraoka D, Kobayashi Y, Kakimi K, Yamaguchi R, Matsuo K, Yamamoto K, Fujiwara K, Huang RY, Tan DSP, Hasegawa K.
Ogasawara A, et al. Among authors: nagao s.
Gynecol Oncol. 2024 Oct 15;191:124-131. doi: 10.1016/j.ygyno.2024.09.023. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 39413557